Skip to main content
SpringerLink
Log in

Multidisciplinary Care

  • Chapter
  • First Online:
Lung Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 170))

Abstract

Optimal multidisciplinary care of the lung cancer patient at all stages should encompass integration of the key relevant medical specialties, including not only medical, surgical, and radiation oncology, but also pulmonology, interventional and diagnostic radiology, pathology, palliative care, and supportive services such as physical therapy, case management, smoking cessation, and nutrition. Multidisciplinary management starts at staging and tissue diagnosis with pathologic and molecular phenotyping, extends through selection of a treatment modality or modalities, management of treatment and cancer-related symptoms, and to survivorship and end-of-life care. Well-integrated multidisciplinary care may reduce treatment delays, improve cancer-specific outcomes, and enhance quality of life. We address key topics and areas of ongoing investigation in multidisciplinary decision making at each stage of the lung cancer treatment course for early-stage, locally advanced, and metastatic lung cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. http://www.cancer.gov/dictionary?cdrid=322893. Cited 25 May 2015

  2. Cancer, A.C.o.S.C.o (2012) Cancer program standards 2012: ensuring patient-centered care V1.0, in American College of Surgeons, Chicago

    Google Scholar 

  3. El Saghir N et al (2014) Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide, in ASCO Educational Book

    Google Scholar 

  4. Wright FC et al (2007) Multidisciplinary cancer conferences: a systematic review and development of practice standards. Eur J Cancer 43(6):1002–1010

    Article  CAS  PubMed  Google Scholar 

  5. Schmidt HM et al (2015) Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: a prospective cohort study. Ann Thorac Surg 99(5):1719–1724

    Article  PubMed  Google Scholar 

  6. Ung, KA et al (2014) Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer. Asia Pac J Clin Oncol

    Google Scholar 

  7. Hazin R, Qaddoumi I (2010) Teleoncology: current and future applications for improving cancer care globally. Lancet Oncol 11(2):204–210

    Article  PubMed  PubMed Central  Google Scholar 

  8. Heifetz LJ et al (2011) A model for rural oncology. J Oncol Pract 7(3):168–171

    Article  PubMed  PubMed Central  Google Scholar 

  9. Freeman RK et al (2010) The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. Eur J Cardiothorac Surg 38(1):1–5

    Article  PubMed  Google Scholar 

  10. Kesson EM et al (2012) Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ 344:e2718

    Article  PubMed  PubMed Central  Google Scholar 

  11. Keating NL et al (2013) Tumor boards and the quality of cancer care. J Natl Cancer Inst 105(2):113–121

    Article  PubMed  PubMed Central  Google Scholar 

  12. Blayney DW (2013) Tumor boards (team huddles) aren’t enough to reach the goal. J Natl Cancer Inst 105(2):82–84

    Article  PubMed  Google Scholar 

  13. Devitt B, Philip J, McLachlan SA (2013) Re: tumor boards and the quality of cancer care. J Natl Cancer Inst 105(23):1838

    Article  PubMed  Google Scholar 

  14. Krasna M, Freeman RK, Petrelli NJ (2013) Re: tumor boards and the quality of cancer care. J Natl Cancer Inst 105(23):1839–1840

    Article  PubMed  Google Scholar 

  15. Lamb BW et al (2013) Improving decision making in multidisciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1421 patients. J Am Coll Surg 217(3):412–420

    Article  PubMed  Google Scholar 

  16. Schwaederle M et al (2014) Molecular tumor board: The University of California San Diego Moores Cancer Center experience. Oncologist 19(6):631–636

    Article  PubMed  PubMed Central  Google Scholar 

  17. www.clinicaltrials.gov Lung-MAP: S1400 biomarker-targeted second-line therapy in treating patients with recurrent stage IIIB-IV squamous cell lung cancer. Cited 9 June 2015

  18. www.clinicaltrials.gov NCI-MATCH: targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphomas. cited 9 June 2015

  19. Annema JT et al (2010) Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 304(20):2245–2252

    Article  CAS  PubMed  Google Scholar 

  20. Sharples LD et al (2012) Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial. Health Technol Assess 16(18):1–75, iii–iv

    Google Scholar 

  21. Silvestri GA et al (2013) Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e211S–50S

    Article  PubMed  Google Scholar 

  22. Cooke DT et al (2014) Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer. J Thorac Cardiovasc Surg 148(1):36–40

    Article  CAS  PubMed  Google Scholar 

  23. Lindeman NI et al (2013) Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the study of lung cancer, and association for molecular pathology. J Thorac Oncol 8(7):823–859

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Gomez DR et al (2015) Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. Radiother Oncol

    Google Scholar 

  25. Diaconescu R, Lafond C, Whittom R (2011) Treatment delays in non-small cell lung cancer and their prognostic implications. J Thorac Oncol 6(7):1254–1259

    Article  PubMed  Google Scholar 

  26. Everitt S et al (2013) The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer. Radiother Oncol 106(3):288–291

    Article  PubMed  Google Scholar 

  27. Kishan AU et al (2014) Quantification of gross tumour volume changes between simulation and first day of radiotherapy for patients with locally advanced malignancies of the lung and head/neck. J Med Imaging Radiat Oncol 58(5):618–624

    Article  PubMed  Google Scholar 

  28. Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60(3):615–622; discussion 622–623

    Google Scholar 

  29. Chi A et al (2010) Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 94(1):1–11

    Article  PubMed  Google Scholar 

  30. Timmerman R et al (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303(11):1070–1076

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. www.clinicaltrials.gov (2015) Randomized Study to compare cyber knife to surgical resection in stage I non-small cell lung cancer (STARS). Cited 26 May 2015

  32. www.clinicaltrials.gov (2015) Trial of either surgery or stereotactic radiotherapy for early stage (IA) lung cancer (ROSEL). Cited 26 May 2015

  33. www.clinicaltrials.gov (2015) Surgery with or without internal radiation therapy compared with stereotactic body radiation therapy in treating patients with high-risk stage I non-small cell lung cancer. Cited 26 May 2015

  34. Chang JY et al (2015) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16(6):630–637

    Article  PubMed  PubMed Central  Google Scholar 

  35. van Meerbeeck JP et al (2007) Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99(6):442–450

    Article  PubMed  Google Scholar 

  36. Albain KS et al (2009) Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 374(9687):379–386

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Robinson LA et al (2007) Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):243S–265S

    Article  PubMed  Google Scholar 

  38. Tanner NT et al (2012) Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol 7(2):365–369

    Article  PubMed  PubMed Central  Google Scholar 

  39. Albain KS et al (1995) Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13(8):1880–1892

    CAS  PubMed  Google Scholar 

  40. Deutsch M et al (1994) Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer 74(4):1243–1252

    Article  CAS  PubMed  Google Scholar 

  41. Fowler WC et al (1993) Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55(4):986–989

    Article  CAS  PubMed  Google Scholar 

  42. Suntharalingam M et al (2012) Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 84(2):456–463

    Article  PubMed  Google Scholar 

  43. Sonett JR et al (1999) Safe pulmonary resection after chemotherapy and high-dose thoracic radiation. Ann Thorac Surg 68(2):316–320

    Article  CAS  PubMed  Google Scholar 

  44. Sze WM et al (2004) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy—a systematic review of the randomised trials. Cochrane Database Syst Rev 15(2): CD004721

    Google Scholar 

  45. Tong D, Gillick L, Hendrickson FR (1982) The palliation of symptomatic osseous metastases: final results of the study by the radiation therapy oncology group. Cancer 50(5):893–899

    Article  CAS  PubMed  Google Scholar 

  46. Serafini AN et al (1998) Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 16(4):1574–1581

    CAS  PubMed  Google Scholar 

  47. Robinson RG et al (1995) Strontium 89 therapy for the palliation of pain due to osseous metastases. JAMA 274(5):420–424

    Article  CAS  PubMed  Google Scholar 

  48. Cheung G et al (2006) Percutaneous vertebroplasty in patients with intractable pain from osteoporotic or metastatic fractures: a prospective study using quality-of-life assessment. Can Assoc Radiol J 57(1):13–21

    PubMed  Google Scholar 

  49. Klepstad P et al (2014) The evidence of peripheral nerve blocks for cancer-related pain: a systematic review. Minerva Anestesiol

    Google Scholar 

  50. Lee JW et al (2015) The efficacy of external beam radiotherapy for airway obstruction in lung cancer patients. Cancer Res Treat 47(2):189–196

    Article  CAS  PubMed  Google Scholar 

  51. Stevens R et al (2015) Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer. Cochrane Database Syst Rev 1: CD002143

    Google Scholar 

  52. Manali ED et al (2010) High dose-rate endobronchial radiotherapy for proximal airway obstruction due to lung cancer: 8-year experience of a referral center. Cancer Biother Radiopharm 25(2):207–213

    Article  PubMed  Google Scholar 

  53. de Aquino Gorayeb MM et al (2013) High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction: a quantitative assessment. Brachytherapy 12(5): 471–478

    Google Scholar 

  54. Louie AV et al (2013) Radiotherapy for intubated patients with malignant airway obstruction: futile or facilitating extubation? J Thorac Oncol 8(11):1365–1370

    Article  PubMed  Google Scholar 

  55. Temel JS et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742

    Article  CAS  PubMed  Google Scholar 

  56. Thomas PA et al (2014) National perioperative outcomes of pulmonary lobectomy for cancer: the influence of nutritional status. Eur J Cardiothorac Surg 45(4):652–659; discussion 659

    Google Scholar 

  57. Bagan P et al (2013) Nutritional status and postoperative outcome after pneumonectomy for lung cancer. Ann Thorac Surg 95(2):392–396

    Article  PubMed  Google Scholar 

  58. Harpole DH Jr et al (1999) Prognostic models of thirty-day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg 117(5):969–979

    Article  PubMed  Google Scholar 

  59. van der Meij BS et al (2011) Nutrition during trimodality treatment in stage III non-small cell lung cancer: not only important for underweight patients. J Thorac Oncol 6(9):1563–1568

    Article  PubMed  Google Scholar 

  60. Illa P, Tomiskova M, Skrickova J (2015) Nutritional risk screening predicts tumor response in lung cancer patients. J Am Coll Nutr 1–5

    Google Scholar 

  61. Bourdel-Marchasson I et al (2014) Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS ONE 9(9):e108687

    Article  PubMed  PubMed Central  Google Scholar 

  62. Ovesen L et al (1993) Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 11(10):2043–2049

    CAS  PubMed  Google Scholar 

  63. Holden DA et al (1992) Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest 102(6):1774–1779

    Article  CAS  PubMed  Google Scholar 

  64. Marjanski T et al (2015) Patients who do not reach a distance of 500 m during the 6-min walk test have an increased risk of postoperative complications and prolonged hospital stay after lobectomydagger. Eur J Cardiothorac Surg 47(5):e213–e219

    Article  PubMed  Google Scholar 

  65. Bade BC et al (2015) Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol 10(6):861–871

    Article  PubMed  Google Scholar 

  66. Mishra SI et al (2012) Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 8:CD008465

    Google Scholar 

  67. Cavalheri V et al (2013) Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. Cochrane Database Syst Rev 7: CD009955

    Google Scholar 

  68. Arbane G et al (2011) Evaluation of an early exercise intervention after thoracotomy for non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength and exercise tolerance: randomised controlled trial. Lung Cancer 71(2):229–234

    Article  PubMed  Google Scholar 

  69. Brocki B et al (2010) Rehabilitation after lung cancer operation—a randomised controlled study. In: Annals ERS Annual Congress 2010

    Google Scholar 

  70. Stigt JA et al (2013) A randomized controlled trial of postthoracotomy pulmonary rehabilitation in patients with resectable lung cancer. J Thorac Oncol 8(2):214–221

    Article  PubMed  Google Scholar 

  71. Karam-Hage M, Cinciripini PM, Gritz ER (2014) Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin 64(4):272–290

    Article  PubMed  PubMed Central  Google Scholar 

  72. Warren GW et al (2013) Smoking at diagnosis and survival in cancer patients. Int J Cancer 132(2):401–410

    Article  CAS  PubMed  Google Scholar 

  73. Bellizzi KM et al (2005) Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 23(34):8884–8893

    Article  PubMed  Google Scholar 

  74. Cooley ME et al (2012) Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer. Lung Cancer 76(2):144–149

    Article  PubMed  Google Scholar 

  75. Walker MS et al (2006) Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev 15(12):2370–2377

    Article  CAS  PubMed  Google Scholar 

  76. Surveillance, Epidemiology, and End Results Program (2015) SEER stat fact sheets: lung and bronchus cancer. cited 31 May 2015

    Google Scholar 

  77. Riely GJ et al (2006) Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin Cancer Res 12(3 Pt 1):839–844

    Article  CAS  PubMed  Google Scholar 

  78. Win T et al (2007) The effect of lung resection on pulmonary function and exercise capacity in lung cancer patients. Respir Care 52(6):720–726

    PubMed  Google Scholar 

  79. Kirby TJ et al (1995) Lobectomy–video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg 109(5): 997–1001; discussion 1001–1002

    Google Scholar 

  80. Stanic S et al (2011) Rib fracture following stereotactic body radiotherapy: a potential pitfall. Clin Nucl Med 36(11):e168–e170

    Article  PubMed  Google Scholar 

  81. Cella L et al (2014) Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role? PLoS ONE 9(10):e111753

    Article  PubMed  PubMed Central  Google Scholar 

  82. Dunlap NE et al (2010) Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(3):796–801

    Article  PubMed  Google Scholar 

  83. Yun YH et al (2013) Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancer. Ann Oncol 24(6):1552–1559

    Article  CAS  PubMed  Google Scholar 

  84. Rauma V et al (2015) Long-term lung cancer survivors have permanently decreased quality of life after surgery. Clin Lung Cancer 16(1):40–45

    Article  PubMed  Google Scholar 

  85. Surapaneni R et al (2012) Stage I lung cancer survivorship: risk of second malignancies and need for individualized care plan. J Thorac Oncol 7(8):1252–1256

    Article  PubMed  Google Scholar 

  86. Hewitt M, Greenfield S, Stovall E (eds) (2005) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC

    Google Scholar 

  87. Cancer, C.o. (2012) Cancer program standards 2012: Ensuring Patient-Centered Care

    Google Scholar 

  88. Boekhout AH et al (2015) A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial. J Cancer Surviv

    Google Scholar 

  89. Hershman DL et al (2013) Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat 138(3):795–806

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, 4501 X Street, Sacramento, CA, 95817, USA

    Megan E. Daly

  2. Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis Comprehensive Cancer Center, 4501 X Street, Sacramento, CA, 95817, USA

    Jonathan W. Riess

Authors
  1. Megan E. Daly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan W. Riess
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Megan E. Daly or Jonathan W. Riess .

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, City of Hope, Duarte, California, USA

    Karen L. Reckamp

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Daly, M.E., Riess, J.W. (2016). Multidisciplinary Care. In: Reckamp, K. (eds) Lung Cancer. Cancer Treatment and Research, vol 170. Springer, Cham. https://doi.org/10.1007/978-3-319-40389-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-40389-2_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-40387-8

  • Online ISBN: 978-3-319-40389-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation